Austar Lifesciences Ltd. (AULSF)
Austar Lifesciences Market Cap : 35.88M for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| WuXi Biologics (Cayman), Inc. | 17.57B |
| WuXi AppTec Co., Ltd. | 49.87B |
| Viva Biotech Holdings | 427.92M |
| Genscript Biotech Corp. | 3.769B |
| Pharmaron Beijing Co., Ltd. | 3.546B |
Market Cap Related Metrics
| PE Ratio | 7.692 |
| PS Ratio | 0.1683 |
| Price to Free Cash Flow | 2.508 |
| Price | 0.07 |
| Earnings Yield | 13.00% |
| Operating PE Ratio | 9.586 |
| Normalized PE Ratio | 8.140 |